China SXT Pharmaceuticals (SXTC) stock whipsaws after AI “clinics” plan, with Friday open in focus
China SXT Pharmaceuticals shares plunged 37.5% to $1.25 Thursday, with volume surging to 109.3 million from 115,000 the day before. The company announced an AI initiative for product planning and offline consultation stores but gave no cost or timeline. Shares traded at $1.48 after hours. U.S. jobs data is due at 8:30 a.m. EST.
